SGMO icon

Sangamo Therapeutics

193 hedge funds and large institutions have $571M invested in Sangamo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

16% less capital invested

Capital invested by funds: $679M → $571M (-$107M)

Holders
193
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.57M
Puts
$5.1M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$87.5M
2
$82.2M
3
$70.1M
4
$46.5M
5
$26.9M
6
$16.7M
7
$16.7M
8
$11.9M
9
$11.6M
10
$9.78M
11
$9.67M
12
$9.28M
13
$9.26M
14
$9.13M
15
$7.14M
16
$6.38M
17
$6.37M
18
$5.97M
19
$5.82M
20
$4.96M
21
$4.89M
22
$4.84M
23
$4.54M
24
$4.51M
25
$4.5M